Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Knutson

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2010
Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cellsJohn M Davis, Keith L Knutson, Michael A Strausbauch, et al.
The American Journal of Gastroenterology|November 19, 2021
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy ControlsFreddy Caldera, Keith L Knutson, Sumona Saha, et al.
Plos One|November 19, 2013
The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancerClaudia C Preston, Matthew J Maurer, Ann L Oberg, et al.
Arthritis Research & Therapy|November 26, 2013
Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunityJohn M Davis, Keith L Knutson, Michael A Strausbauch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2013
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancerAaron M Carlson, Matthew J Maurer, Krista M Goergen, et al.
American Heart Journal|October 8, 2013
Rheumatoid arthritis and cardiovascular diseaseCynthia S Crowson, Katherine P Liao, John M Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Immunoediting of cancers may lead to epithelial to mesenchymal transitionKeith L Knutson, Hailing Lu, Brad Stone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapyClare Taylor, Dawn Hershman, Nina Shah, et al.
Journal for Immunotherapy of Cancer|November 25, 2018
Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodiesAixa E Soyano, Bhagirathbhai Dholaria, Julian A Marin-Acevedo, et al.
JCO Precision Oncology|October 31, 2022
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine TherapySarah Sammons, Kira Raskina, Natalie Danziger, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2010
Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cellsJohn M Davis, Keith L Knutson, Michael A Strausbauch, et al.
The American Journal of Gastroenterology|November 19, 2021
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy ControlsFreddy Caldera, Keith L Knutson, Sumona Saha, et al.
Plos One|November 19, 2013
The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancerClaudia C Preston, Matthew J Maurer, Ann L Oberg, et al.
Arthritis Research & Therapy|November 26, 2013
Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunityJohn M Davis, Keith L Knutson, Michael A Strausbauch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2013
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancerAaron M Carlson, Matthew J Maurer, Krista M Goergen, et al.
American Heart Journal|October 8, 2013
Rheumatoid arthritis and cardiovascular diseaseCynthia S Crowson, Katherine P Liao, John M Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Immunoediting of cancers may lead to epithelial to mesenchymal transitionKeith L Knutson, Hailing Lu, Brad Stone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapyClare Taylor, Dawn Hershman, Nina Shah, et al.
Journal for Immunotherapy of Cancer|November 25, 2018
Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodiesAixa E Soyano, Bhagirathbhai Dholaria, Julian A Marin-Acevedo, et al.
JCO Precision Oncology|October 31, 2022
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine TherapySarah Sammons, Kira Raskina, Natalie Danziger, et al.
Pageof 15